MX2014001940A - Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. - Google Patents

Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Info

Publication number
MX2014001940A
MX2014001940A MX2014001940A MX2014001940A MX2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A MX 2014001940 A MX2014001940 A MX 2014001940A
Authority
MX
Mexico
Prior art keywords
oral
administration
nasal inhalation
aerosol product
pharmaceutical aerosol
Prior art date
Application number
MX2014001940A
Other languages
English (en)
Inventor
Helgert Müller
Renate Engelstätter
Ulrich Bildmann
Andrea Bauer
Paul Mcglynn
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of MX2014001940A publication Critical patent/MX2014001940A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a un producto farmacéutico de aerosol adecuado para administración por inhalación oral o nasal, y a su uso en el tratamiento de enfermedades respiratorias, en particular en el tratamiento de los niños. La composición de aerosol comprende ciclesonida, etanol y 1,1,1,2-tetrafluoroetano o 1,1,1,2,3,3,3-heptafluoro propano.
MX2014001940A 2011-08-18 2012-08-13 Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal. MX2014001940A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161524803P 2011-08-18 2011-08-18
EP11178042 2011-08-19
PCT/EP2012/065812 WO2013024070A1 (en) 2011-08-18 2012-08-13 Pharmaceutical aerosol product for administration by oral or nasal inhalation

Publications (1)

Publication Number Publication Date
MX2014001940A true MX2014001940A (es) 2014-03-27

Family

ID=47714798

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001940A MX2014001940A (es) 2011-08-18 2012-08-13 Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Country Status (6)

Country Link
US (2) US11007150B2 (es)
EP (1) EP2744479A1 (es)
AU (1) AU2012296880A1 (es)
CA (1) CA2844944A1 (es)
MX (1) MX2014001940A (es)
WO (1) WO2013024070A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014001940A (es) * 2011-08-18 2014-03-27 Takeda Gmbh Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718355A (en) 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
US5421482A (en) 1989-02-03 1995-06-06 Senetics, Inc. Indicator device responsive to axial force
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
DE69105212T2 (de) 1990-10-18 1995-03-23 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
US5290539A (en) 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
JP3172190B2 (ja) 1993-07-15 2001-06-04 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医薬エアロゾルを配給するための器具
US5474758A (en) 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
US5505192A (en) 1993-11-12 1996-04-09 New-Med Corporation Dispenser monitoring system
GB2288259A (en) 1994-03-30 1995-10-11 Norton Healthcare Ltd Inhaler dose counter
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
NZ306280A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US5871007A (en) 1997-06-09 1999-02-16 Chase Marketing International L.L.C. Throat spray counting mechanism
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
FR2842905B1 (fr) 2002-07-29 2005-05-13 Valois Sa Indicateur de doses pour dispositif de distribution de produit fluide
US20040023935A1 (en) 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
FR2850192B1 (fr) 2003-01-20 2005-05-06 Tebro Indicateur de doses pour dispositif de distribution de produit fluide.
JP2006527237A (ja) * 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
FR2857770B1 (fr) 2003-07-18 2005-10-21 Valois Sas Indicateur de doses ameliore pour dispositif de distribution de produit fluide.
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
GB0328502D0 (en) 2003-12-10 2004-01-14 3M Innovative Properties Co Metered dose dispensers and assemblies therefor
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
US8517019B2 (en) 2006-03-03 2013-08-27 3M Innovative Properties Company Method and apparatus for metered dose dispensing
MX2014001940A (es) * 2011-08-18 2014-03-27 Takeda Gmbh Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.

Also Published As

Publication number Publication date
AU2012296880A1 (en) 2014-03-27
US20140170081A1 (en) 2014-06-19
US11992556B2 (en) 2024-05-28
WO2013024070A1 (en) 2013-02-21
EP2744479A1 (en) 2014-06-25
US11007150B2 (en) 2021-05-18
US20210267888A1 (en) 2021-09-02
CA2844944A1 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
AU2018201997B2 (en) Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
EP2749277A3 (en) Combination of glycopyrronium and vilanterol
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
SG11201804449WA (en) 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
WO2014064410A3 (en) Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
HK1146485A1 (es)
MY179703A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
MX367674B (es) Composición farmacéutica de dosis fija estable que comprende mometasona y olopatadina.
TR201000680A2 (tr) Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler
PH12017502087A1 (en) Tiotropium inhalation solution for nebulization
MY175804A (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX2015004362A (es) Derivados de ketamina.
MX336225B (es) Composiciones que comprenden sulfato de salbutamol.
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
WO2012040228A3 (en) Aerosol composition for administering drugs
WO2014007772A3 (en) Inhalation compositions comprising glucose anhydrous
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
WO2014007781A3 (en) Inhalation compositions
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
CY1117596T1 (el) Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
ECSP055821A (es) Nueva formulacion pulverulenta que contiene tiotropio destinado a la inhalación